[96a5a0]: / output / allTrials / identified / NCT00674973_identified.json

Download this file

245 lines (245 with data), 9.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
{
"info": {
"nct_id": "NCT00674973",
"official_title": "A Phase II Biomarker Identification Trial for Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Carcinoma",
"inclusion_criteria": "* adult patients, >=18 years of age;\n* histologically or cytologically documented locally advanced-unresectable or metastatic pancreatic cancer;\n* measurable disease according to RECIST;\n* failure of at least one prior chemotherapy regimen, or who are deemed unsuitable for chemotherapy;\n* ECOG performance status of 0-2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* local or locally advanced-resectable pancreatic cancer;\n* any other malignancies within last 5 years, except for adequately treated cancer in situ of the cervix, or basal or squamous cell skin cancer;\n* major surgery within 2 weeks prior to randomization.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* adult patients, >=18 years of age;",
"criterions": [
{
"exact_snippets": "adult patients, >=18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* histologically or cytologically documented locally advanced-unresectable or metastatic pancreatic cancer;",
"criterions": [
{
"exact_snippets": "histologically or cytologically documented",
"criterion": "documentation method",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "locally advanced-unresectable or metastatic pancreatic cancer",
"criterion": "pancreatic cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced-unresectable",
"metastatic"
]
}
]
}
]
},
{
"line": "* measurable disease according to RECIST;",
"criterions": [
{
"exact_snippets": "measurable disease according to RECIST",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "standard",
"expected_value": "RECIST"
}
]
}
]
},
{
"line": "* failure of at least one prior chemotherapy regimen, or who are deemed unsuitable for chemotherapy;",
"criterions": [
{
"exact_snippets": "failure of at least one prior chemotherapy regimen",
"criterion": "prior chemotherapy regimen",
"requirements": [
{
"requirement_type": "failure",
"expected_value": true
}
]
},
{
"exact_snippets": "deemed unsuitable for chemotherapy",
"criterion": "suitability for chemotherapy",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": false
}
]
}
]
},
{
"line": "* ECOG performance status of 0-2.",
"criterions": [
{
"exact_snippets": "ECOG performance status of 0-2.",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* local or locally advanced-resectable pancreatic cancer;",
"criterions": [
{
"exact_snippets": "local or locally advanced-resectable pancreatic cancer",
"criterion": "pancreatic cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"local",
"locally advanced-resectable"
]
}
]
}
]
},
{
"line": "* any other malignancies within last 5 years, except for adequately treated cancer in situ of the cervix, or basal or squamous cell skin cancer;",
"criterions": [
{
"exact_snippets": "any other malignancies within last 5 years",
"criterion": "other malignancies",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "adequately treated cancer in situ of the cervix",
"criterion": "cancer in situ of the cervix",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
]
},
{
"exact_snippets": "basal or squamous cell skin cancer",
"criterion": "basal or squamous cell skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* major surgery within 2 weeks prior to randomization.",
"criterions": [
{
"exact_snippets": "major surgery within 2 weeks prior to randomization",
"criterion": "major surgery",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "weeks"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}